| abstract |
The present application relates to a method for the purification of recombinant coagulation factor proteins including, for example, prothrombin (Factor II). In embodiments, the method provides a purified prothrombin with increased biological activity and decreased thrombin levels, thereby increasing the safety of the prothrombin. Purified recombinant coagulation factor proteins are also provided. |